liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
PT-141 Palatin.
Linköping University, Department of Medical and Health Sciences, Clinical Pharmacology. Linköping University, Faculty of Health Sciences.
2004 (English)In: Current opinion in investigational drugs (London, England : 2000), ISSN 1472-4472, Vol. 5, no 4, 456-62 p.Article in journal (Refereed) Published
Abstract [en]

Palatin, under license from Competitive Technology, is developing the peptide PT-141, a synthetically modified analog of PT-14, as a nasal spray for the potential treatment of erectile dysfunction (ED) and female sexual dysfunction. In September 2003, Palatin had completed a phase IIb trial in patients with ED and in February 2004, Palatin planned to start phase III trials in early 2005.

Place, publisher, year, edition, pages
2004. Vol. 5, no 4, 456-62 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-77658PubMedID: 15134289OAI: diva2:528215
Available from: 2012-05-24 Created: 2012-05-24 Last updated: 2012-05-31

Open Access in DiVA

No full text


Search in DiVA

By author/editor
Hedlund, Petter
By organisation
Clinical PharmacologyFaculty of Health Sciences
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 33 hits
ReferencesLink to record
Permanent link

Direct link